S. Legault-Poisson

发表

A randomized clinical trial evaluating sequential methotrexate and fluorouracil in the treatment of patients with node-negative breast cancer who have estrogen-receptor-negative tumors.

C. Redmond, R. Foster, D. Wickerham, 1989, The New England journal of medicine.

The Prognostic Significance of Preoperative Carcinoembryonic Antigen Levels in Colorectal Cancer: Results from NSABP Clinical Trials

N. Wolmark, B. Fisher, N. Dimitrov, 1984 .

Isolation of the human anionic glutathione S-transferase cDNA and the relation of its gene expression to estrogen-receptor content in primary breast cancer.

K. Cowan, A. Townsend, P. Vickers, 1988, Proceedings of the National Academy of Sciences of the United States of America.

Systemic therapy in patients with node-negative breast cancer. A commentary based on two National Surgical Adjuvant Breast and Bowel Project (NSABP) clinical trials.

C. Redmond, D. Wickerham, N. Wolmark, 1989, Annals of internal medicine.

Postoperative chemotherapy and tamoxifen compared with tamoxifen alone in the treatment of positive-node breast cancer patients aged 50 years and older with tumors responsive to tamoxifen: results from the National Surgical Adjuvant Breast and Bowel Project B-16.

B Fisher, C. Redmond, D. Wickerham, 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Tamoxifen-induced tumor stimulation and withdrawal response.

P. Band, R. Poisson, S. Legault-Poisson, 1979, Cancer treatment reports.

Biologic markers and breast cancer: A multiparametric study—1. Increased serum protein levels

R. Poisson, R. Mandeville, S. Legault-Poisson, 1982, Cancer.

Doxorubicin-containing regimens for the treatment of stage II breast cancer: The National Surgical Adjuvant Breast and Bowel Project experience.

C. Redmond, D. Wickerham, N. Wolmark, 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prolonging tamoxifen therapy for primary breast cancer. Findings from the National Surgical Adjuvant Breast and Bowel Project clinical trial.

C. Redmond, D. Wickerham, N. Wolmark, 1987, Annals of internal medicine.

Adjuvant chemotherapy with and without tamoxifen in the treatment of primary breast cancer: 5-year results from the National Surgical Adjuvant Breast and Bowel Project Trial.

C. Redmond, N. Wolmark, B. Fisher, 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Biological markers and breast cancer. A multiparametric study. II: Depressed immune competence

R. Poisson, R. Mandeville, S. Legault-Poisson, 1982, Cancer.

Biologic markers and breast cancer: a multiparametric study--1. Increased serum protein levels.

R. Poisson, R. Mandeville, S. Legault-Poisson, 1981, Cancer.